or Try an Advanced Search...

    Technical Analysis for TLPH - Talphera, Inc.

    Grade Last Price % Change Price Change
    F 0.71 5.42% 0.04
    TLPH closed up 5.42 percent on Wednesday, November 20, 2024, on 38 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical TLPH trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction 5.42%
    Lower Bollinger Band Walk Weakness 5.42%
    Wide Bands Range Expansion 5.42%
    Lower Bollinger Band Touch Weakness 5.42%
    Oversold Stochastic Weakness 5.42%
    Older End-of-Day Signals for TLPH ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 18 hours ago
    Up 5% about 18 hours ago
    Up 3% about 18 hours ago
    Up 2% about 18 hours ago
    Up 1% about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TLPH Chart by TradingView
    Basic chart:

    Profile

    Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the FDA. Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe. This release is intended for investors only
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Pharmaceutical Medication Medical Equipment FDA Syringe Drug Paraphernalia Innovative Therapies Phenylephrine Investigational Device Exemption

    Is TLPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges
    Nov 13 Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript
    Nov 13 AcelRx Pharmaceuticals GAAP EPS of -$0.13 beats by $0.07
    Nov 13 Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 13 Earnings Scheduled For November 13, 2024
    Nov 12 AcelRx Pharmaceuticals Q3 2024 Earnings Preview
    Nov 6 Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
    Oct 8 Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
    Sep 5 Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 19 Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
    See more TLPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.61
    52 Week Low 0.6103
    Average Volume 98,568
    200-Day Moving Average 0.98
    50-Day Moving Average 0.87
    20-Day Moving Average 0.86
    10-Day Moving Average 0.79
    Average True Range 0.08
    RSI (14) 36.31
    ADX 23.29
    +DI 12.57
    -DI 25.97
    Chandelier Exit (Long, 3 ATRs) 0.79
    Chandelier Exit (Short, 3 ATRs) 0.90
    Upper Bollinger Bands 1.08
    Lower Bollinger Band 0.65
    Percent B (%b) 0.14
    BandWidth 50.55
    MACD Line -0.06
    MACD Signal Line -0.03
    MACD Histogram -0.0275
    Fundamentals Value
    Market Cap 11.98 Million
    Num Shares 17 Million
    EPS
    Price-to-Sales 50.40
    Price-to-Book 0.80
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.77
    Resistance 3 (R3) 0.77 0.74 0.76
    Resistance 2 (R2) 0.74 0.72 0.74 0.76
    Resistance 1 (R1) 0.72 0.71 0.73 0.73 0.75
    Pivot Point 0.70 0.70 0.70 0.70 0.70
    Support 1 (S1) 0.68 0.68 0.69 0.68 0.66
    Support 2 (S2) 0.65 0.67 0.66 0.66
    Support 3 (S3) 0.64 0.65 0.65
    Support 4 (S4) 0.64